Last reviewed · How we verify

NCT06907914

Schroth and Scapular Muscle Activation in Hyperkyphosis

Recruiting now NA Last updated 1 October 2025
What this trial tests

NA trial testing Schroth in Hyperkyphosis, Adolescent in 56 participants. Currently enrolling.

Timeline
15 June 2025
Primary endpoint
1 May 2026
1 August 2026

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment56
Start date15 June 2025
Primary completion1 May 2026
Estimated completion1 August 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 7 to 18, any sex, with Hyperkyphosis, Adolescent or Muscle Activation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to investigate the effects of Schroth exercises on scapular muscle activation in children with thoracic hyperkyphosis. A total of 56 participants will be randomly assigned to either the Schroth exercise group or the control group receiving postural education. The intervention group will complete an 8-week supervised Schroth program focusing on three-dimensional correction, rotational breathing, and postural awareness. Primary outcome is scapular muscle activation measured by surface EMG. Secondary outcomes include muscle strength, scapular endurance, kyphotic appearance, posture, and pain. The results will guide clinical management and preventive strategies for children with postural thoracic hyperkyphosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Schroth

Trials testing the same drug.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06907914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing